How Much Does Ambien (Zolpidem) Cost in Oregon in 2026?

Oregon Cash Prices for Zolpidem in 2026

The average cash-pay price for a 30-day supply of generic zolpidem 10 mg in Oregon is approximately $15 in 2026. That figure reflects standard immediate-release tablets dispensed at retail chain pharmacies including Walgreens, Fred Meyer, Costco, and Rite Aid locations across the state.

Brand-name Ambien, manufactured by Sanofi, carries a list price near $120 for the same 30-day supply. Because multiple generic manufacturers (Teva, Mylan, Aurobindo, and others) produce zolpidem tartrate, competition has driven retail pricing well below the branded product. Costco and Walmart pharmacies in Portland, Eugene, and Salem frequently price generic zolpidem under $10 for 30 tablets without insurance. Prices at independent pharmacies tend to run $12 to $25 depending on the supplier contract and dispensing volume.

Zolpidem extended-release (Ambien CR) generics cost more. Expect $25 to $55 per month cash-pay for the 12.5 mg ER formulation. The intermezzo sublingual tablet (1.75 mg or 3.5 mg for middle-of-the-night dosing) sits higher still, averaging $45 to $90 depending on pharmacy. Price-comparison tools like GoodRx, RxSaver, and the Mark Cuban Cost Plus Drug Company offer additional discount pathways, often pulling the immediate-release generic below $8.

The FDA approved zolpidem in 1992 for the short-term treatment of insomnia characterized by difficulty with sleep initiation [1]. A 2010 polysomnographic study by Krystal et al. (N=212) confirmed that zolpidem 10 mg reduced latency to persistent sleep by a mean of 22.8 minutes versus placebo over 5 weeks [2]. That efficacy profile, combined with generic availability, explains why zolpidem remains one of the most-prescribed hypnotics nationally.

Oregon Medicaid Coverage for Zolpidem

Oregon Health Plan (OHP) covers zolpidem, but prescribers must obtain prior authorization before dispensing. Oregon Medicaid manages its preferred drug list (PDL) through the Oregon Health Authority's Drug Use Review (DUR) Board, and zolpidem falls under the sedative-hypnotic class subject to PA requirements.

The PA process typically requires documentation that the patient has a diagnosed insomnia disorder, has attempted non-pharmacologic interventions (such as cognitive behavioral therapy for insomnia, or CBT-I), and has no contraindicated concurrent medications. Approval durations vary but commonly span 6 to 12 months before renewal is required. Generic zolpidem immediate-release is more likely to receive PA approval than extended-release or brand-name formulations. The Oregon Health Authority emphasizes CBT-I as first-line treatment for chronic insomnia, consistent with the American Academy of Sleep Medicine (AASM) 2023 clinical practice guideline recommending CBT-I before pharmacotherapy [3].

For patients whose PA is denied, the appeals process runs through the OHP managed care organization (MCO). Oregon has 16 coordinated care organizations (CCOs) that administer benefits regionally. Each CCO may have slightly different turnaround times for PA decisions, though federal Medicaid rules require a response within 24 hours for urgent requests and 14 days for standard requests.

Patients enrolled in OHP who receive a denied PA should ask their prescriber to submit a letter of medical necessity citing prior treatment failures. The 2017 American College of Physicians (ACP) guideline on insomnia management supports pharmacotherapy when CBT-I alone is insufficient, providing clinical backing for appeal letters [4].

Insurance Coverage Beyond Medicaid

Most commercial insurers operating in Oregon place generic zolpidem on Tier 1 or Tier 2 of their formularies. That means copays typically range from $0 to $15 per fill.

Major Oregon-market insurers and their general zolpidem positioning include:

Providence Health Plan. Generic zolpidem IR sits on Tier 1. Copays run $5 to $10 for a 30-day supply depending on the plan tier. Brand Ambien requires Tier 3 copay ($40 to $70) and may need step therapy documentation showing generic failure.

Regence BlueCross BlueShield of Oregon. Generic zolpidem is Tier 1 preferred. The extended-release generic requires Tier 2 copay. Brand products are non-preferred Tier 3 with prior authorization.

Kaiser Permanente Northwest. Kaiser's integrated pharmacy model dispenses generic zolpidem with standard Tier 1 copays. Kaiser clinicians typically prescribe within their own formulary, and zolpidem IR is well-established on that list.

Moda Health. Generic zolpidem is Tier 1 on most Moda plans sold through the Oregon Health Insurance Marketplace (healthcare.gov exchange plans). Moda covers the Portland metro and several rural Oregon counties.

PacificSource Health Plans. Headquartered in Springfield, PacificSource lists generic zolpidem as Tier 1 preferred across its commercial and marketplace offerings.

For uninsured or underinsured patients, manufacturer savings programs have limited applicability because Sanofi's brand-name Ambien savings card typically excludes generic-eligible prescriptions. The savings card, when applicable to brand Ambien, may reduce out-of-pocket cost to $25 to $40 per fill for commercially insured patients, but it cannot be used with Medicare Part D, Medicaid, or other federal programs.

Compounded Zolpidem in Oregon

Oregon permits licensed 503A compounding pharmacies to prepare patient-specific zolpidem formulations. A 503A pharmacy operates under a valid prescription for an individual patient, as distinguished from 503B outsourcing facilities that produce larger batches without patient-specific prescriptions.

Compounded zolpidem may be appropriate for patients who need a dose not commercially available, require a different delivery form (sublingual troche, topical cream, or liquid suspension), or cannot tolerate inactive ingredients in manufactured tablets. Oregon Board of Pharmacy regulations require that compounding pharmacies hold a current Oregon pharmacy license and comply with USP <795> standards for non-sterile compounding.

Pricing for compounded zolpidem varies significantly by pharmacy. Some 503A pharmacies in Portland and Bend price compounded zolpidem troches between $30 and $60 for a 30-day supply, depending on dose and formulation complexity. Insurance coverage for compounded medications is inconsistent. Most commercial plans and Medicaid do not cover compounded zolpidem unless the prescriber demonstrates medical necessity for a formulation unavailable commercially.

Patients should verify that any compounding pharmacy they use holds current Oregon Board of Pharmacy accreditation. The board maintains a searchable license verification database at its website. The FDA has increased scrutiny of compounding pharmacies nationally following safety concerns, and Oregon's regulatory framework aligns with federal standards under the Drug Quality and Security Act of 2013 [5].

Telehealth Prescribing of Zolpidem in Oregon

Oregon law permits prescribing zolpidem via telehealth. The state adopted permanent telehealth flexibilities following the pandemic-era expansions, and the Oregon Medical Board allows providers to prescribe Schedule IV controlled substances after a synchronous audio-video visit that establishes a valid provider-patient relationship.

DEA regulations still require that the prescribing clinician hold an active DEA registration. Following the DEA's 2025 final rule on telemedicine prescribing of controlled substances, providers must conduct an initial video evaluation before prescribing Schedule II through V drugs remotely. Zolpidem, as a Schedule IV substance, falls squarely within these parameters [6].

Several telehealth platforms serve Oregon patients seeking zolpidem prescriptions. Visit costs typically run $50 to $150 for an initial insomnia consultation, with follow-up visits priced lower. Some platforms bundle the consultation fee with pharmacy fulfillment. Oregon patients should confirm that their telehealth provider is licensed in Oregon, holds a valid DEA registration, and sends prescriptions to an Oregon-licensed pharmacy.

The AASM position statement on telehealth and sleep medicine, published in the Journal of Clinical Sleep Medicine, supports remote evaluation for uncomplicated insomnia but recommends in-person or video-based sleep studies for patients with suspected obstructive sleep apnea or other comorbid sleep disorders [7]. Prescribers who identify red flags during a telehealth insomnia visit (loud snoring, witnessed apneas, excessive daytime sleepiness with an Epworth score above 10) should refer for polysomnography before prescribing zolpidem.

How to Reduce Your Zolpidem Cost in Oregon

Several concrete strategies can bring your out-of-pocket zolpidem expense below the $15 average.

Use a pharmacy discount coupon. GoodRx, RxSaver, and Amazon Pharmacy discount cards frequently price generic zolpidem IR 10 mg #30 at $4 to $8 at participating Oregon pharmacies. These coupons are free and do not require insurance.

Fill at Costco. Oregon law does not require a Costco membership to use the pharmacy. Costco's member pricing on generics is often among the lowest in the state, with zolpidem sometimes priced below $5 for 30 tablets.

Ask about 90-day fills. If your prescriber writes a 90-day supply and your pharmacy offers 90-day pricing, the per-tablet cost drops further. Some insurers also offer reduced copays for 90-day mail-order fills.

Check the Mark Cuban Cost Plus Drug Company. Cost Plus Drugs applies a transparent markup model (manufacturer cost plus 15% plus $5 dispensing fee plus $5 shipping). Generic zolpidem pricing through this channel is competitive, though shipping times may be longer than local pickup.

Oregon Prescription Drug Program (OPDP). Oregon operates a state discount program for residents without prescription drug coverage. The OPDP aggregates purchasing power to negotiate discounts. Enrollment is free and available to any Oregon resident who lacks prescription drug insurance for outpatient medications.

Patient Assistance Programs. NeedyMeds and RxAssist maintain databases of manufacturer and charitable assistance programs. While brand-name Ambien patient assistance from Sanofi has been limited since generic entry, some charitable organizations provide support for patients meeting income thresholds.

A 2021 analysis published in JAMA Network Open found that pharmacy-level price variation for common generics, including zolpidem, could exceed 600% within a single metropolitan area, reinforcing the value of price comparison before filling [8].

Safety Considerations and Dosing

The FDA revised zolpidem dosing recommendations in 2013, lowering the recommended starting dose for women to 5 mg (immediate-release) and 6.25 mg (extended-release) based on pharmacokinetic data showing higher morning blood levels in women [9]. Men should start at 5 mg or 10 mg IR, with the lower dose recommended for elderly patients.

Zolpidem carries an FDA boxed warning for complex sleep behaviors, including sleepwalking, sleep-driving, and engaging in activities while not fully awake. These behaviors can occur after the first dose or after prolonged use. Patients with a history of complex sleep behaviors on any sedative-hypnotic should not take zolpidem [9].

The recommended treatment duration is short-term, generally 2 to 4 weeks. The prescribing information states that if insomnia persists beyond 7 to 10 days of treatment, re-evaluation for underlying conditions is appropriate. The FDA advises against exceeding 10 mg per day for immediate-release or 12.5 mg per day for extended-release formulations.

Drug interactions merit attention. Concurrent use of zolpidem with opioids, benzodiazepines, alcohol, or other CNS depressants increases the risk of profound sedation, respiratory depression, and death. The FDA issued a Drug Safety Communication in 2016 requiring boxed warnings on both opioid and benzodiazepine labels about concurrent use risks, and zolpidem's label includes parallel cautionary language [10].

Oregon providers should also be aware of the state's Prescription Drug Monitoring Program (PDMP). Oregon law requires prescribers to check the PDMP before issuing a new Schedule II through IV controlled substance prescription, including zolpidem. The PDMP query takes seconds through the Oregon Health Authority's online portal and helps identify patients who may be receiving duplicate prescriptions from multiple providers.

Generic vs. Brand: Is There a Clinical Difference?

The FDA considers generic zolpidem therapeutically equivalent to brand Ambien (rated AB in the Orange Book), meaning bioequivalence studies demonstrated that generics deliver the same active ingredient at the same rate and extent of absorption [11].

Some patients report subjective differences between generic manufacturers. A 2017 survey-based study in the Journal of Clinical Sleep Medicine found that 10.2% of patients switching from brand to generic zolpidem reported perceived reduced efficacy, though blinded crossover trials have not confirmed pharmacokinetic differences [12]. The bioequivalence standard allows a 90% confidence interval of 80% to 125% for Cmax and AUC parameters, which the FDA maintains is clinically insignificant for zolpidem.

For Oregon patients concerned about generic variability, requesting a specific manufacturer (such as Teva or Mylan) and filling consistently at the same pharmacy can provide batch consistency. Pharmacists can accommodate manufacturer preferences when stock permits, though availability depends on wholesale contracts.

The cost difference between brand and generic is substantial. At $120 versus $15 per month, a patient paying cash saves $1,260 annually by choosing generic. Even with insurance, brand Ambien's Tier 3 copay ($40 to $70) far exceeds generic Tier 1 copays ($0 to $15).